Comorbid conditions with obesity in children

Authors

  • Oleksandr Abaturov Dnipro State Medical University
  • Anna Nikulina Dnipro State Medical University

DOI:

https://doi.org/10.53457/2022.1.2

Keywords:

metabolically unhealthy obesity, metabolically healthy obesity, impaired carbohydrate tolerance, arterial hypertension, dyslipidemia, metabolically associated fatty liver disease

Abstract

The metabolic-associated fatty liver disease is the most frequent comorbid condition found in various phenotypes of obesity in children

References

Smith JD, Fu E, Kobayashi MA. Prevention and Management of Childhood Obesity and Its Psychological and Health Comorbidities. Annu Rev Clin Psychol. 2020;16:351-378. doi: 10.1146/annurev-clinpsy-100219-060201

Lonardo A, Mantovani A, Lugari S, et al. Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity. Ann Hepatol. 2020;S1665-2681(20)30023-5. doi: 10.1016/j.aohep.2020.03.001

Abaturov A, Nikulina A. Genotype C/C 13910 of the Lactase Gene as a Risk Factor for the Formation of Insulin-Resistant Obesity in Children. Acta Medica (Hradec Kralove). 2019;62(4):150-155. doi: 10.14712/18059694.2020.4

Sagar R, Gupta T. Psychological Aspects of Obesity in Children and Adolescents. Indian J Pediatr. 2018;85(7):554-559. doi: 10.1007/s12098-017-2539-2

Davies MJ, Aroda V, Collins BS et al. Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2022. doi: 10.1007/s00125-022-05787-2

Ruiz LD, Zuelch ML, Dimitratos SM, et al. Adolescent Obesity: Diet Quality, Psychosocial Health, and Cardiometabolic Risk Factors. Nutrients. 2019;12(1):43. doi: 10.3390/nu12010043.

Kumar S, Kelly AS. Review of Childhood Obesity: From Epidemiology, Etiology, and Comorbidities to Clinical Assessment and Treatment. Mayo Clin Proc. 2017;92(2):251-265. doi: 10.1016/j.mayocp.2016.09.017

Styne DM, Arslanian SA, Connor EL, et al. Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2017;102(3):709-757. doi: 10.1210/jc.2016-2573

Peplies J, Jiménez-Pavón D, Savva SC, et al. IDEFICS consortium. Percentiles of fasting serum insulin, glucose, HbA1c and HOMA-IR in pre-pubertal normal weight European children from the IDEFICS cohort. Int J Obes (Lond). 2014 Sep;38 (2):39-47. doi: 10.1038/ijo.2014.134

Vos MB, Abrams SH, Barlow SE, et al. NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr. 2017;64(2):319-334. doi: 10.1097/MPG.0000000000001482

Lee KJ, Moon JS, Kim NY, et al. Effects of PNPLA3, TM6SF2 and SAMM50 on the development and severity of non-alcoholic fatty liver disease in children. Pediatr Obes. 2022;17(2):e12852. doi: 10.1111/ijpo.12852

Ruiz LD, Zuelch ML, Dimitratos SM, et al. Adolescent Obesity: Diet Quality, Psychosocial Health, and Cardiometabolic Risk Factors. Nutrients. 2019;12(1):43. doi: 10.3390/nu1201004

Downloads

Published

2023-07-17

Issue

No. 1 (2022)

Section

Abstract

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.